# BlackRock Discloses 12.72% Voting Stake in QIAGEN

- URL: https://stocks.freetheai.org/news/blackrock-discloses-12-72-voting-stake-in-qiagen-558bb5
- Published: 2026-10-14T20:05:22Z
- Category: company_news; sentiment: neutral; impact: low
- Symbols: [NYSE:QGEN](https://stocks.freetheai.org/symbols/NYSE-QGEN)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Asset manager BlackRock has disclosed a total capital interest of 11.35% and 12.72% of voting rights in life sciences company QIAGEN N.V. (NYSE:QGEN). The position, updated as of October 7, 2026, was reported through the Dutch Authority for the Financial Markets on October 13, 2026. Shares of QIAGEN were trading at $45.49, up 0.11% on the day.

The holdings are distributed indirectly across multiple BlackRock entities and include both direct capital positions and contracts for difference. This distributed structure reflects broad exposure through index vehicles and passive strategies rather than an activist stake.

Going forward, investors will watch for future regulatory filings to track any threshold crossings or shifts in voting power. Changes in derivative positions or total indirect holdings could influence market liquidity and trading float.

## Key points

- BlackRock reported an 11.35% capital interest and 12.72% voting stake in QIAGEN N.V.
- The positions were reported via the Dutch regulator AFM with an effective date of October 7, 2026.
- Holdings are distributed indirectly across BlackRock entities and include contracts for difference.
- Shares of QIAGEN N.V. (NYSE:QGEN) traded at $45.49, up 0.11% today.

## Questions and answers

### What is BlackRock's voting stake in QIAGEN N.V.?

BlackRock controls 12.72% of voting rights and an 11.35% capital interest in QIAGEN N.V. as of October 7, 2026.

### How does BlackRock hold its QIAGEN shares?

The stake is held indirectly across various BlackRock entities and includes both equity positions and contracts for difference (CFDs).

### When was the QIAGEN regulatory filing disclosed?

The notification was made via the Dutch AFM on October 13, 2026.